| Plan length | Tirzepatide | Semaglutide | Unit | Source · read |
|---|---|---|---|---|
| Month to month | $129 | $109 | USD per month | nexlife.us, read Nov 6, 2026 |
| 3 months | $125 | $105 | USD per month | nexlife.us, read Nov 6, 2026 |
| 6 months | $119 | $99 | USD per month | nexlife.us, read Nov 6, 2026 |
| 12 months | $115 | $95 | USD per month | nexlife.us, read Nov 6, 2026 |
| 12-month total | $1,380 | $1,140 | USD per year | $115 × 12; $95 × 12 |
What the price includes, and what it does not
NexLife’s plan pages list the medication, medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 customer support and free expedited shipping. They say the price is the same at every dose and that there are no memberships or contracts.
Lab work is not listed as included on any NexLife page we read. FSA and HSA cards can be used for eligible portions; the all-plans pages mention Klarna and Afterpay, the microdose and ODT pages Klarna and Affirm, and the FAQ all three.
Pharmacies and medical oversight
The plan pages say prescriptions are filled by Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA), described as state-licensed 503A compounding pharmacies. NexLife names Adam Kennah, MD (NPI 1144260043) as medical director. A prescription is not guaranteed: a licensed clinician reviews each intake.
Three inconsistencies on NexLife’s own site are worth knowing. Its FAQ (updated November 14, 2026) and pharmacy-partners page name two pharmacies, Absolute and Boudreaux’s, while the plan pages still list three, and its microdose and ODT pages refer to “503A & 503B” facilities without names. Its FAQ says NexLife is available in 45 states and D.C. (not Alabama, Louisiana, Mississippi, Virginia or West Virginia), while its states page says all 50 states and D.C.; NexLife confirms eligibility by state at checkout. And the microdose and ODT pages carry a money-back banner whose terms do not match its guarantee policy page, which we quote below.
FDA warning letter 730096
FDA’s Center for Drug Evaluation and Research sent NexLife warning letter MARCS-CMS 730096, dated June 8, 2026 and posted June 16, 2026, after reviewing nexlife.us in March 2026. FDA said the site’s representations about compounded semaglutide and tirzepatide were false or misleading, in part because pictured labels named “Nexlife” as if it were the compounder when it is not. NexLife’s own page says it responded, most recently on September 21, 2026, and that as of November 12, 2026 FDA had not published a close-out letter. FDA’s index showed no close-out when we searched it on November 20, 2026. A warning letter is not a recall or a finding that a product is unsafe, but it costs NexLife 4 of the 10 regulatory-disclosure points in our score. Eden Health received a similar letter the same day.
Billing, cancellation and the guarantee
Plans renew until you cancel, and cancellations take effect after 30 days, so one more shipment may be charged. The plan pages also say 3-, 6- and 12-month plans start only if you are prescribed and that unshipped months are refunded if treatment stops; its FAQ (updated November 14, 2026) says the 3-, 6- and 12-month plans are paid upfront, in full, at checkout: $375, $714 or $1,380 for tirzepatide and $315, $594 or $1,140 for semaglutide. The plan pages still say plans “continue monthly unless canceled”, and an older cancellation policy says members pay monthly, so confirm the charge schedule before you pay. Once medication ships, that order is final.
New since October: a Price Match Guarantee for new members switching from another licensed U.S. telehealth program with an active compounded tirzepatide or semaglutide prescription. NexLife says it matches that program’s regular all-in month-to-month price on NexLife’s own month-to-month plan; introductory offers and prepaid rates are not matched, and people with Medicare, Medicaid or TRICARE coverage are excluded. It is a conditional offer, not a published price, so we do not use it in any comparison.
The guarantee policy refunds program and membership fees, not medication, if a member loses less than 5% of starting body weight over six months, subject to conditions listed in the FAQ below.
Other NexLife programs
| Program | Monthly | 3 months | 6 months | 12 months | Status |
|---|---|---|---|---|---|
| Microdose tirzepatide | $129 | $125 | $119 | $115 | Verified; the same as the standard plan since November 8, 2026 |
| Sublingual tirzepatide (ODT) | $229 | $219 | $205 | $199 | Verified |
| Sublingual semaglutide (ODT) | $199 | $185 | $177 | $165 | Verified |
| Microdose semaglutide | $109 | $105 | $99 | $95 | Verified; the same as the standard plan since November 8, 2026 |
Pros and cons
Pros
- The same monthly price at every dose, so the cost does not rise as the dose goes up.
- No membership fee on top of the medication.
- Names its 503A pharmacies and its medical director before you pay.
- Coaching call, nutrition plan and support included.
Cons
- Compounded semaglutide and tirzepatide are not FDA-approved and are not Wegovy, Ozempic, Zepbound or Mounjaro.
- Price check: month to month, Mondae lists $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (read November 20, 2026).
- Lab work is not listed as included.
- An FDA warning letter (730096, June 8, 2026) with no published close-out.
- 30-day cancellation notice, and conflicting state, pharmacy and billing statements across its own pages.
Our score: 86/100 on the v4.1 methodology
NexLife scores 86 of 100 on our v4.1 methodology, which weights pricing transparency 20, total annual cost 20, clinical oversight 15, pharmacy transparency 15, support 10, regulatory disclosure 10 and accessibility 10. That is the highest score of the ten GLP-1 programs we scored from pages read November 20, 2026, so NexLife ranks first in our directory on the computed result; it is not a separate editorial placement. Its score was 94 on October 15, 2026; it fell to 86 after we published a category-by-category scoring guide and applied it to every program the same way.
| Category | Points | What we found |
|---|---|---|
| Pricing transparency | 16 of 20 | Flat all-inclusive price for every plan length (8) and the same at every dose (4); its own pages conflict on some prices, such as an ODT FAQ total that does not match the plan tile and a guarantee example that still uses the old $139 price (2 of 4), and on billing, where the FAQ says multi-month plans are paid upfront and the plan pages say they “continue monthly” (2 of 4). |
| Total annual cost | 20 of 20 | $1,140 a year for semaglutide on the 12-month plan. |
| Clinical oversight | 15 of 15 | Physicians with NexLife Medical Group P.C. review and prescribe (5); medical group and medical director named (5); ongoing medical guidance with physician access during clinical hours (5). |
| Pharmacy transparency | 11 of 15 | Pharmacies named, but the lists conflict: three on the plan pages, two in the FAQ (8 of 10); 503A on the plan pages, “503A & 503B” on the microdose pages (3 of 5). |
| Support | 10 of 10 | 24/7 support (5); nutrition plan and a coach call included (5). |
| Regulatory disclosure | 6 of 10 | Says plainly that compounded medications are not FDA-approved (6); FDA warning letter 730096 has no close-out in FDA’s index (0 of 4). |
| Accessibility | 8 of 10 | State lists conflict: FAQ 45 states and D.C., states page all 50 (2 of 4); HSA/FSA and pay-later options (3); cancellation terms stated (3). |
| Total | 86 of 100 | Rank 1 of the 10 GLP-1 programs scored on November 20, 2026; Eden Health is second at 78. |
Frequently asked questions
How much does NexLife cost per month?
As of November 6, 2026, unchanged on November 20, NexLife lists compounded tirzepatide at $129 a month on the month-to-month plan, $125 on 3 months, $119 on 6 months and $115 on 12 months, and compounded semaglutide at $109, $105, $99 and $95. The price is the same at every dose and there is no membership fee. A 12-month plan totals $1,380 for tirzepatide or $1,140 for semaglutide, which NexLife's FAQ says is paid upfront at checkout. Cancellations take effect after 30 days.
Which pharmacies fill NexLife prescriptions?
NexLife’s tirzepatide and semaglutide plan pages, read November 20, 2026, name Absolute Pharmacy in Lutz, Florida, Premium Compounding in Decatur, Alabama and Boudreaux’s New Drug Store in Lake Charles, Louisiana, and describe them as state-licensed 503A compounding pharmacies. Its FAQ, updated November 14, 2026, names only Absolute and Boudreaux’s, so ask which pharmacy will fill your order.
Are lab tests included in NexLife’s price?
No NexLife page we read on November 20, 2026 says lab work is included. The plan pages list the medication, medical guidance from NexLife Medical Group, a GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping. Ask during intake whether your clinician will order labs and who pays for them.
Does NexLife offer a money-back guarantee?
Only partly. The guarantee covers program and membership fees, never the medication, for members who lose under 5% of their starting weight in six months. To qualify you must have enrolled on or after January 1, 2026, stayed on treatment 180 days in a row with no refill gaps, logged your weight at least every two weeks, started at a BMI of 30 or higher, and filed between days 181 and 210.
Is NexLife the cheapest compounded GLP-1 program?
No. NexLife’s 12-month prices are $115 for tirzepatide and $95 for semaglutide. Price check: on November 20, 2026 Mondae listed semaglutide at $87 month to month and tirzepatide at $114 a month on a prepaid 6-month plan. Some programs advertise lower prices that depend on a sale, prepayment or membership.
Sources
- NexLife: tirzepatide plans, nexlife.us, read November 6, 2026.
- NexLife: semaglutide plans, nexlife.us, read November 6, 2026.
- NexLife: frequently asked questions, read November 20, 2026.
- NexLife: guarantee policy, read November 20, 2026.
- Eden Health: GLP-1 weight loss, read November 20, 2026.
- Mondae: compounded tirzepatide, read November 20, 2026 (portfolio price research).
- FDA warning letter 730096 to Nexlife Inc. dba Nexlife, dated June 8, 2026, read November 20, 2026.
- NexLife: statement on the FDA warning letter, read November 20, 2026.
- NexLife: states page and pharmacy partners page, read November 20, 2026.
- NexLife: Price Match Guarantee terms, read November 20, 2026.
- FDA: concerns with unapproved GLP-1 drugs used for weight loss, content current as of October 1, 2026.